BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8825201)

  • 1. Characterization of subtypes of gamma-aminobutyric acid receptors in an Ascaris muscle preparation by binding assay and binding of PF1022A, a new anthelmintic, on the receptors.
    Chen W; Terada M; Cheng JT
    Parasitol Res; 1996; 82(2):97-101. PubMed ID: 8825201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action.
    Harder A; Schmitt-Wrede HP; Krücken J; Marinovski P; Wunderlich F; Willson J; Amliwala K; Holden-Dye L; Walker R
    Int J Antimicrob Agents; 2003 Sep; 22(3):318-31. PubMed ID: 13678839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel arylaminopyridazine-GABA receptor antagonists examined electrophysiologically in Ascaris suum.
    Martin RJ; Sitamze JM; Duittoz AH; Wermuth CG
    Eur J Pharmacol; 1995 Mar; 276(1-2):9-19. PubMed ID: 7781700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel azole derivatives are antagonists at the inhibitory GABA receptor on the somatic muscle cells of the parasitic nematode Ascaris suum.
    Bascal Z; Holden-Dye L; Willis RJ; Smith SW; Walker RJ
    Parasitology; 1996 Feb; 112 ( Pt 2)():253-9. PubMed ID: 8851866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the anthelmintic drug PF1022A on mammalian tissue and cells.
    Dornetshuber R; Kamyar MR; Rawnduzi P; Baburin I; Kouri K; Pilz E; Hornbogen T; Zocher R; Berger W; Lemmens-Gruber R
    Biochem Pharmacol; 2009 Apr; 77(8):1437-44. PubMed ID: 19426683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA receptors on the somatic muscle cells of the parasitic nematode, Ascaris suum: stereoselectivity indicates similarity to a GABAA-type agonist recognition site.
    Holden-Dye L; Krogsgaard-Larsen P; Nielsen L; Walker RJ
    Br J Pharmacol; 1989 Nov; 98(3):841-50. PubMed ID: 2556203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 2-hydroxy-saclofen, an antagonist of GABAB action, upon the binding of baclofen and other receptor ligands in rat cerebrum.
    al-Dahan MI; Tehrani MH; Thalmann RH
    Brain Res; 1990 Sep; 526(2):308-12. PubMed ID: 2175242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes.
    Bowery NG; Hill DR; Hudson AL
    Br J Pharmacol; 1983 Jan; 78(1):191-206. PubMed ID: 6297646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiology and pharmacology of neuromuscular transmission in the nematode parasite, Ascaris suum.
    Martin RJ; Pennington AJ; Duittoz AH; Robertson S; Kusel JR
    Parasitology; 1991; 102 Suppl():S41-58. PubMed ID: 1647516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of GABA receptors.
    Enna SJ; McCarson KE
    Curr Protoc Pharmacol; 2013 Dec; 63():1.7.1-1.7.20. PubMed ID: 24510754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profiles of the GABA and acetylcholine receptors from the nematode, Ascaris suum.
    Walker RJ; Colquhoun L; Holden-Dye L
    Acta Biol Hung; 1992; 43(1-4):59-68. PubMed ID: 1338558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures.
    Chaudieu I; St-Pierre JA; Quirion R; Boksa P
    Eur J Pharmacol; 1994 Nov; 264(3):361-9. PubMed ID: 7698177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum.
    Willson J; Amliwala K; Harder A; Holden-Dye L; Walker RJ
    Parasitology; 2003 Jan; 126(Pt 1):79-86. PubMed ID: 12613766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gamma-hydroxybutyrate in GABA(B)(1)-deficient mice.
    Kaupmann K; Cryan JF; Wellendorph P; Mombereau C; Sansig G; Klebs K; Schmutz M; Froestl W; van der Putten H; Mosbacher J; Bräuner-Osborne H; Waldmeier P; Bettler B
    Eur J Neurosci; 2003 Nov; 18(10):2722-30. PubMed ID: 14656321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of PF1022A on the motility of Angiostrongylus cantonensis in vitro.
    Kachi S; Terada M; Hashimoto H
    Parasitol Res; 1997; 83(6):578-82. PubMed ID: 9211510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes.
    Drew CA; Johnston GA; Weatherby RP
    Neurosci Lett; 1984 Dec; 52(3):317-21. PubMed ID: 6097844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-[4-(3,3-Dimethylbutoxycarbonyl)phenyl]-4-pentynoic acid and its derivatives inhibit ionotropic gamma-aminobutyric acid receptors by binding to the 4'-ethynyl-4-n-propylbicycloorthobenzoate site.
    Hamano H; Nagata K; Fukada TN; Shimotahira H; Ju XL; Ozoe Y
    Bioorg Med Chem; 2000 Mar; 8(3):665-74. PubMed ID: 10732984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baclofen binding sites in rat kidney.
    Erdö SL
    Eur J Pharmacol; 1990 Aug; 184(2-3):305-9. PubMed ID: 1964128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased emodepside sensitivity in unc-49 γ-aminobutyric acid (GABA)-receptor-deficient Caenorhabditis elegans.
    Miltsch SM; Krücken J; Demeler J; Janssen IJ; Krüger N; Harder A; von Samson-Himmelstjerna G
    Int J Parasitol; 2012 Jul; 42(8):761-70. PubMed ID: 22727682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral GABAB agonists stimulate gastric acid secretion in mice.
    Piqueras L; Martinez V
    Br J Pharmacol; 2004 Jul; 142(6):1038-48. PubMed ID: 15210585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.